Philip Morris International (PM)
(Delayed Data from NYSE)
$120.89 USD
+0.47 (0.39%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $121.00 +0.11 (0.09%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$120.89 USD
+0.47 (0.39%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $121.00 +0.11 (0.09%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Zacks News
3 Tobacco Stocks to Watch Out For on RRPs and Pricing Gains
by Vidya Nair
The Zacks Tobacco industry gains from reduced-risk products and solid pricing. Such upsides have been benefiting companies like Philip Morris (PM), Altria (MO) and Turning Point Brands (TPB). However, regulatory headwinds in cigarettes are a concern.
Top Research Reports for Microsoft, Amazon & NextEra Energy
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amazon.com, Inc. (AMZN), and NextEra Energy, Inc. (NEE).
Philip Morris (PM) Strives to Expand IQOS & Beyond Nicotine
by Zacks Equity Research
Philip Morris (PM) is gaining from growing consumer acceptance for IQOS devices. It is on track with the expansion of Beyond Nicotine products to support inhaled therapeutics.
Philip Morris (PM) Secures More than 74% Stake in Vectura
by Zacks Equity Research
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
Philip Morris (PM) Buys Fertin Pharma, Announces Dividend Hike
by Zacks Equity Research
Philip Morris (PM) buys Fertin Pharma to attain its target of becoming a majority smoke-free company by 2025. The company also raises its quarterly dividend.
Altria (MO) Benefits From Low-Risk Products, High Pricing
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.
The Zacks Analyst Blog Highlights: Adobe, Thermo Fisher, BHP Group, Philip Morris and Chubb
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Adobe, Thermo Fisher, BHP Group, Philip Morris and Chubb
Top Stock Reports for Adobe, Thermo Fisher & BHP Group
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Thermo Fisher Scientific Inc. (TMO), and BHP Group (BHP).
Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.
Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth
by Zacks Equity Research
Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.
Factors Likely to Influence Brown-Forman's (BF.B) Q1 Earnings
by Zacks Equity Research
Brown-Forman's (BF.B) Q1 results are expected to reflect gains from strong underlying sales across regions, brand investments, and the reopening of on-premise and tourism across several markets.
Why Is Philip Morris (PM) Up 4.6% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philip Morris (PM) Fuels Smoke-Free Offerings With IQOS ILUMA
by Zacks Equity Research
Philip Morris International (PM) unveils the launch of IQOS ILUMA. These bladeless devices generate no smoke and combustion, and will strengthen the company's smoke-free portfolio.
Philip Morris (PM) Boosts Beyond Nicotine Options With OtiTopic
by Zacks Equity Research
Philip Morris (PM) acquires OtiTopic to expand offerings in the inhaled therapeutics and respiratory drug delivery platform. The move is part of the company's Beyond Nicotine strategy.
How Has Philip Morris' Q2 Earnings Beat Impacted Staples ETFs?
by Sweta Jaiswal, FRM
Here we highlight some consumer staples ETFs with significant exposure to Philip Morris (PM) since its earnings release.
Philip Morris (PM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Philip Morris' (PM) second-quarter performance reflects gains from growth in revenues from combustible and RRPs categories as well as favorable pricing variance in several markets.
Philip Morris (PM) Tops Q2 Earnings Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 1.95% and -3.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Philip Morris (PM) This Earnings Season?
by Zacks Equity Research
Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Things Worth Noting Before Philip Morris' (PM) Q2 Earnings
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2021 results are likely to reflect solid pricing power and strength in reduced risk products. However, duty-free business is likely to show weakness.
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) to Divest Ste. Michelle Wine Estates Business
by Zacks Equity Research
Altria's (MO) subsidiary agrees to sell Ste. Michelle Wine Estates business. The move will boost shareholders' value, while aiding in smooth transition of adult smokers to a non-combustible future.
Company News for Jul 12, 2021
by Zacks Equity Research
Companies In The News Are: LEVI, PM, UAL, MO
Why Philip Morris (PM) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Altria (MO) Up 14% in 6 Months, Gains on Low-Risk Products
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, strong pricing for tobacco products is an upside.
Things Worth Noting Before Helen of Troy's (HELE) Q1 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2022 results are likely to reflect strength in Leadership Brands and online sales, though elevated costs might be a worry.